GI
Genomenon, Inc.
SEC filingBiotechnology · Ann Arbor, MI
Amount raised$6Msold at filing
Total offering$10M$4M still open
Investors in the raise30count reported to the SEC
FiledJul 30, 2026first sale Jul 15, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Sam GlobusExecutive Officer
Michael GrossDirector
David GregorkaDirector
Michael KleinExecutive Officer, Director
Mark KielExecutive Officer, Director
Patricia GlazaDirector
Brian GroarkExecutive Officer
Executive officers, directors and promoters as listed on the Form D.